Treatment Of Shallow Periodontal Pockets 4-6mm Using AIRFLOW Prophylaxis Master Device With Erythritol vs Manual Scalers

April 4, 2024 updated by: Asim Tariqu Al Ammour, Cairo University

Evaluation Of Nonsurgical Treatment Of Shallow Periodontal Pockets (4-6mm) Using AIRFLOW® Prophylaxis Master Device With Erythritol Powder vs Conventional Instrumentation: A Randomized Controlled Clinical Trial

Periodontitis is a chronic condition associated with the inflammatory destruction of the periodontal tissues ultimately leading to tooth loss. Clinically, it is identified by key features such as clinical attachment loss (CAL), bleeding upon probing (BOP), and an increase in probing pocket depth (PPD), and/or gingival recession. Periodontitis is mediated by polymicrobial dysbiosis with keystone pathogens affecting the virulence of the entire biofilm community. The removal of this biofilm and its retention factors is the ultimate goal of clinical treatment and oral measures applied. The elimination of the biofilm has traditionally been achieved with the use of either hand instruments or power driven devices. Promoting periodontal health or diminishing bacterial presence and calculus buildup on teeth can be accomplished with the same efficacy whether using manual scalers and curettes or ultrasonic scaling instruments.

Both hand and ultrasonic instruments are characterized by being time-consuming and requiring technical skill, often causing patient discomfort and post-treatment pain, including hypersensitivity resulting from the loss of hard tissue when scaling the tooth surface. Ultrasonic instruments tend to leave a rougher surface behind compared to hand instruments. While effective the current techniques all have their disadvantages.

The aim of this study is to evaluate changes in probing depth clinically, Bleeding on probing, Clinical attachment level, Plaque index, Calculus index, Patient pain/discomfort, Patient satisfaction, Cost effectiveness, Treatment time and Number of pockets closed after using AIRFLOW® Prophylaxis Master device with erythritol powder.

Study Overview

Detailed Description

Patients will be selected from the outpatient clinic of the Oral Medicine and Periodontology Department, Faculty of Dentistry-Cairo University

  • Screening of patients will continue until the target sample is achieved. (Consecutive sampling)
  • Identifying and recruiting potential subjects will be achieved through patient database.

Preoperative evaluation:

- Clinical examination

Each patient will be examined to confirm that he/she met the eligibility criteria.

Age, gender and smoking status will be collected at baseline, along with a complete periodontal charting including 6-point pocket probing depth (PPD), clinical attachment level (CAL), plaque index (PI) according to a modified O'Leary index (O'Leary et al. 1972) measured on 6 surfaces per tooth (distobuccal, buccal, mesiobuccal, distolingual, lingual and mesiolingual), Calculus index according to (Ramfjord SP. 1967).

Periapical x-rays will be taken to confirm the diagnosis of periodontitis.

  • Clinical photographs Clinical photographs will be taken at baseline, immediately after treatment and 6 months after treatment.
  • Radiographic examination Periapicals radiographs will be taken at the site of interest at baseline and after 3 and 6 months.
  • Surgical procedure

Test sites:

  1. Disclosure of biofilm with erythrosine,
  2. Removal of supragingival and subgingival (up to 4 mm) biofilm and stains with the use of AIRFLOW® Master Piezon® with AIRFLOW® PLUS powder (EMS- Dental, Nyon Switzerland).
  3. Supra- and sub- gingival debridement by using the AIRFLOW® Master Piezon® device with Piezon NO PAIN® (EMS-Dental) technology.

Controls will receive conventional treatment with the combination of ultrasonic and hand instrumentation only. Pockets ≥4 mm will be subgingivally debrided using the piezo device according to manufacturer's instructions, and hand curettes will be used until the operator considers the surfaces to be sufficiently clean and free of deposits.

- Postoperative: At the end of the session, the patients will receive oral hygiene instructions on manual toothbrushing and the use of interdental cleaning devices.

Study Type

Interventional

Enrollment (Estimated)

46

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Cairo, Egypt
        • Recruiting
        • Faculty of Dentistry, Cairo University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Systemically healthy patients.
  • Patients with an age range between 16 to 80 years.
  • Patients have a minimum of 20 teeth.
  • Periodontitis patients with at least one residual pocket with a probing depth ranging from 4 to 6 mm.
  • Cooperative patients able and willing to come for follow up appointments.

Exclusion Criteria:

  • Pregnant and lactation females.
  • Patients reporting systemic conditions (eg: diabetes).
  • Patients with severe or unstable upper respiratory tract infections, chronic bronchitis/asthma.
  • Patients with severe inflammation and/or osteonecrosis.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Hand and ultrasonic scalers and curettes
Hand and ultrasonic scalers and curettes will be used for supra- and subgingival instrumentation.
Combination of ultrasonic and hand instrumentation only. Pockets ≥4 mm will be subgingivally debrided using the piezo device according to manufacturer's instructions, and hand curettes will be used until the operator considers the surfaces to be sufficiently clean and free of deposits.
Active Comparator: Electro Medical Systems AIRFLOW® Prophylaxis Master Device With Erythritol Powder
An erythritol powder will be used by Electro Medical Systems AIRFLOW® Prophylaxis Master Device.
  1. Disclosure of biofilm with erythrosine,
  2. Removal of supragingival and subgingival (up to 4 mm) biofilm and stains with the use of AIRFLOW® Master Piezon® with AIRFLOW® PLUS powder (EMS- Dental, Nyon Switzerland).
  3. Supra- and sub- gingival debridement by using the AIRFLOW® Master Piezon® device with Piezon NO PAIN® (EMS-Dental) technology.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in probing pocket depth
Time Frame: PPD will be taken at baseline, 1 month, 3 months and 6months after the intervention during the follow-up period and will be done by a single calibrated examiner.
The PPD will be clinically measured by using UNC 15 periodontal probe from the gingival margin to the depth of the pocket.
PPD will be taken at baseline, 1 month, 3 months and 6months after the intervention during the follow-up period and will be done by a single calibrated examiner.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bleeding On Probing
Time Frame: BoP will be taken at baseline, 1 month, 3 months and 6months after the intervention during the follow-up period and will be done by a single calibrated examiner.
The BoP will be clinically measured by using UNC 15 periodontal probe from the CEJ to the gingival margin.
BoP will be taken at baseline, 1 month, 3 months and 6months after the intervention during the follow-up period and will be done by a single calibrated examiner.
Clinical Attachment Level
Time Frame: CAL gain will be taken at baseline, 3 months and 6 months after the intervention during the follow-up period and will be done by a single calibrated examiner.
The CAL will be clinically measured using UNC 15 periodontal probe from the cemento-enamel junction (CEJ) to the depth of defect.
CAL gain will be taken at baseline, 3 months and 6 months after the intervention during the follow-up period and will be done by a single calibrated examiner.
Plaque index
Time Frame: PI will be measured baseline, 1 month, 3 months and 6 months after the intervention during the follow-up period and will be done by a single calibrated examiner
The PI will be evaluated by using modified O'Leary index teeth are stained with a disclosing solution, presence of plaque is scored on a dichotomous variable and the final score per individual is the sum of the plaque scores divided by the number of surfaces examined.
PI will be measured baseline, 1 month, 3 months and 6 months after the intervention during the follow-up period and will be done by a single calibrated examiner
Calculus index
Time Frame: CI will be taken at baseline, 1 month, 3 months and 6months after the intervention during the follow-up period and will be done by a single calibrated examiner.

0 =absence of calculus

  1. =supragingival calculus extending only slightly below the free gingival margin (not more than 1 mm.)
  2. = moderate amount of supra and subgingival calculus or subgingival calculus alone
  3. = an abundance of supra and subgingival calculus
CI will be taken at baseline, 1 month, 3 months and 6months after the intervention during the follow-up period and will be done by a single calibrated examiner.
Patient pain/discomfort
Time Frame: Postoperative Pain will be measured after the surgical procedure and 1 month, 3 months and 6 months after the intervention
Postoperative Pain will be measured by using visual analogue score (0-10)
Postoperative Pain will be measured after the surgical procedure and 1 month, 3 months and 6 months after the intervention
Patient satisfaction
Time Frame: Patient satisfaction will be measured after the surgical procedure and 1 month, 3 months and 6 months after the intervention
Patient satisfaction will be measured using a survey.
Patient satisfaction will be measured after the surgical procedure and 1 month, 3 months and 6 months after the intervention
Cost effectiveness
Time Frame: At Baseline and 6 months post-op
Ratio of cost of treatment and time of procedure against the gained clinical benefit
At Baseline and 6 months post-op
Treatment time
Time Frame: Up to 6 months
Time from picking-up the handpiece from the instrument holder to put the handpiece back.
Up to 6 months
Number of healed pockets
Time Frame: 6 months post-op
Pocket depth of <3.5 mm clinically measured by using UNC 15 periodontal probe from the gingival margin to the depth of the pocket.
6 months post-op

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Hani El-Nahas, Professor, Cairo University
  • Study Chair: Omnia Tawfik, Lecturer, Cairo University
  • Principal Investigator: Asim Al Ammour, Bachelor, Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2024

Primary Completion (Estimated)

June 1, 2025

Study Completion (Estimated)

January 1, 2026

Study Registration Dates

First Submitted

March 20, 2024

First Submitted That Met QC Criteria

April 4, 2024

First Posted (Actual)

April 8, 2024

Study Record Updates

Last Update Posted (Actual)

April 8, 2024

Last Update Submitted That Met QC Criteria

April 4, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Periodontitis

Clinical Trials on Hand and ultrasonic scalers and curettes

Subscribe